Thermo Fisher, Wells Fargo, Nutrien And More On CNBC's ‘Final Trades'
On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL).
TMO - Thermo Fisher Scientific Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$623.36
DETAILS
HIGH:
$748.00
LOW:
$520.00
MEDIAN:
$630.00
CONSENSUS:
$623.36
UPSIDE:
3.35%
Stock News
First Look: Apple Unveils Foldable iPhone, Google Invests $15B in AI
Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsAnthropic researcher resigns over AI safety concerns: Jacob Coxon, a
Baird Financial Group Inc. Decreases Position in Thermo Fisher Scientific Inc. $TMO
Baird Financial Group Inc. lowered its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 18.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 167,777 shares of the medical research company's stock after selling 39,226 shares during the quarter. Baird
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More
Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Thermo Fisher Scientific Inc. $TMO Shares Purchased by California State Teachers Retirement System
California State Teachers Retirement System grew its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 49,331.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 282,654,735 shares of the medical research company's stock after acquiring an additional 282,082,924
Should You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
‘Corporate America Is Basically Exterminating Your Career." Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65
Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls, or Social Security decisions.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names ranging from Broadcom to Moderna that could reshape your portfolio positioning.
Why Moderna's Cancer Vaccine Matters to Investors
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance. Laboratories performing absorbance-based analysis are under increasing pressure to generate reliable data.
TMO Stock Could Gain Following the Launch of EMPAD G2 Detector
Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.
37,709 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Beacon Pointe Advisors LLC
Beacon Pointe Advisors LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 37,709 shares of the medical research company's stock, valued at approximately $18,906,000. Several other hedge funds also recently modified their holdings of
Ausdal Financial Partners Inc. Makes New $456,000 Investment in Thermo Fisher Scientific Inc. $TMO
Ausdal Financial Partners Inc. bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 910 shares of the medical research company's stock, valued at approximately $456,000. Several other hedge funds and other
Bank OZK Takes $1.10 Million Position in Thermo Fisher Scientific Inc. $TMO
Bank OZK purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,186 shares of the medical research company's stock, valued at approximately $1,096,000. A number of other
Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific™ EMPAD™ G2 detector, a new detector designed to help researchers see and understand materials in unprecedented detail. EMPAD G2 enables high-speed four-dimensional scanning transmission electron microscopy (4D STEM), an advanced form of electron microscopy that captures far more information about a material than a standard image, helping researchers better.
Delta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC's ‘Final Trades'
On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Delta Air Lines, Inc. (NYSE:DAL).
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap™ Isora™ Mass Spectrometer and Orbitrap Isora Pro Mass Spectrometer, the company's first Orbitrap instruments with a dedicated isotope ratio analysis mode. Together with the Thermo Scientific™ Vanquish™ Duo UHPLC System and new Isotope Discoverer™ Software, the instruments form an integrated workflow designed to make molecular-level isotope ratio analys.
Is TMO Overvalued? DCF Says Worth $491
On August 24, 2026, we conducted a DCF analysis for Thermo Fisher Scientific Inc (TMO) amidst a backdrop of strong price performance, with the stock up 30.6% ov
Avanda Investment Management Pte. Ltd. Invests $2 Million in Thermo Fisher Scientific Inc. $TMO
Avanda Investment Management Pte. Ltd. acquired a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 4,000 shares of the medical research company's stock, valued at approximately $2,005,000. Thermo Fisher Scientific accounts for
Price Targets
Thermo Fisher upgraded to Buy from Neutral at UBS
$730.00
(was $603.02)
UBS
Thermo Fisher initiated with an Outperform at CLSA
$748.00
(was $608.54)
Michael Luo
·
CLSA
Thermo Fisher price target raised to $650 from $600 at Stifel
$650.00
(was $564.75)
Stifel Nicolaus
Thermo Fisher price target raised to $600 from $510 at Piper Sandler
$600.00
(was $568.26)
Piper Sandler
Thermo Fisher price target raised to $650 from $620 at Morgan Stanley
$650.00
(was $568.26)
Morgan Stanley
Thermo Fisher price target raised to $580 from $490 at RBC Capital
$580.00
(was $561.09)
Dan Leonard
·
RBC Capital
Thermo Fisher price target raised to $630 from $585 at Jefferies
$630.00
(was $572.60)
Tycho Peterson
·
Jefferies
Thermo Fisher price target lowered to $570 from $575 at Evercore ISI
$570.00
(was $511.31)
Evercore ISI
Thermo Fisher resumed with a Market Perform at Bernstein
$520.00
(was $505.75)
Bernstein
Thermo Fisher initiated with a Neutral at Piper Sandler
$510.00
(was $482.04)
Piper Sandler
HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold
$540.00
(was $482.08)
Sidharth Sahoo
·
HSBC
Thermo Fisher resumed with a Sector Perform at RBC Capital
$490.00
(was $448.21)
RBC Capital
Thermo Fisher price target lowered to $620 from $670 at Morgan Stanley
$620.00
(was $472.23)
Kallum Titchmarsh
·
Morgan Stanley
Thermo Fisher price target lowered to $600 from $700 at Stifel
$600.00
(was $467.47)
Daniel Arias
·
Stifel Nicolaus
Thermo Fisher price target lowered to $639 from $653 at Baird
$639.00
(was $466.70)
Catherine Ramsey Schulte
·
Robert W. Baird
Thermo Fisher price target raised to $615 from $590 at UBS
$615.00
(was $579.86)
UBS
Thermo Fisher Scientific (TMO) PT Lowered to $683 at TD Cowen
$683.00
(was $580.09)
Wells Fargo
Thermo Fisher price target raised to $653 from $645 at Baird
$653.00
(was $583.12)
Robert W. Baird
Thermo Fisher price target raised to $650 from $625 at Barclays
$650.00
(was $592.16)
Barclays
Thermo Fisher price target raised to $700 from $583 at Stifel
$700.00
(was $606.50)
Daniel Arias
·
Stifel Nicolaus